|
|
|
|
LEADER |
00000cam a2200000Mi 4500 |
001 |
JSTOR_on1347058382 |
003 |
OCoLC |
005 |
20231005004200.0 |
006 |
m o d |
007 |
cr cnu---unuuu |
008 |
221010s2022 enk ob 001 0 eng d |
040 |
|
|
|a YDX
|b eng
|e rda
|c YDX
|d YDX
|d JSTOR
|d OCLCF
|d UKAHL
|d UKMGB
|d SFB
|d CAMBR
|d OCLCO
|
015 |
|
|
|a GBC2E2191
|2 bnb
|
016 |
7 |
|
|a 020711076
|2 Uk
|
020 |
|
|
|a 9781529226348
|q (electronic bk.)
|
020 |
|
|
|a 1529226341
|q (electronic bk.)
|
020 |
|
|
|a 9781529226331
|q (electronic bk.)
|
020 |
|
|
|a 1529226333
|q (electronic bk.)
|
020 |
|
|
|z 1529226325
|
020 |
|
|
|z 9781529226324
|
029 |
1 |
|
|a AU@
|b 000072866318
|
029 |
1 |
|
|a UKMGB
|b 020711076
|
035 |
|
|
|a (OCoLC)1347058382
|
037 |
|
|
|a 22573/ctv2z71fhx
|b JSTOR
|
050 |
|
4 |
|a RA644.C67
|b M67 2022
|
082 |
0 |
4 |
|a 327.5101724
|2 23
|
049 |
|
|
|a UAMI
|
100 |
1 |
|
|a Morgan, Pippa,
|e author.
|
245 |
1 |
0 |
|a China's COVID-19 vaccine supplies to the Global South :
|b between politics and business /
|c Pippa Morgan.
|
264 |
|
1 |
|a Bristol, UK :
|b Bristol University Press,
|c 2022.
|
300 |
|
|
|a 1 online resource.
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
490 |
1 |
|
|a Bristol shorts research
|
504 |
|
|
|a Includes bibliographical references and index.
|
520 |
|
|
|a This book unpacks the political economy of China's COVID-19 vaccine supplies to the Global South. Examining the political and economic forces at play, the book demonstrates how China's vaccine provisions have been determined by a complex set of commercial interests, domestic politics, and geopolitical relationships. The book sheds light on how domestic interests shape China's role in global governance and its international economic engagement. Its analysis contributes to broader academic debates on the politics and economics of crises, as well as offering new insights on how pre-existing political and market forces shape aid and trade in the context of crisis.
|
588 |
|
|
|a Description based on online resource; title from digital title page (viewed on October 21, 2022).
|
505 |
0 |
|
|a Front Cover -- China's Covid-19 Vaccine Supplies to the Global South: Between Politics and Business -- Copyright information -- Table of contents -- List of Figures and Tables -- Notes on the Author -- Acknowledgments -- One Introduction -- COVID-19 and the Global South -- Health impacts -- Economic impacts -- Why understanding Chinese vaccine supplies to the Global South matters -- China, the Global South and crises -- China and the Global South -- Political economy in times of crisis -- Argument, data sources and roadmap -- Framework and argument -- Explaining China's vaccine donations -- Explaining China's sales of vaccines -- Data sources -- Roadmap -- Two Contextualizing China's Position in Global Health -- Health governance in China -- Performance legitimacy and infectious disease management -- China in global health governance -- China's traditional health aid -- China in global health governance institutions -- China in world pharmaceutical markets -- China's commercial pharmaceutical industry opens up -- Innovation driven development -- China in global vaccine markets -- Conclusion -- Three 'Vaccine Diplomacy' -- Narratives on Chinese vaccine supplies -- Explaining the distribution of Chinese vaccine donations -- 'Moving the anti-pandemic barrier forward' -- Maintaining regional stability and supporting established partners -- Alternative arguments -- Following established aid practices -- Illustrative case studies -- Myanmar -- Pakistan -- Conclusion -- Four Market Forces and Commercial Chinese Vaccine Sales -- The world COVID-19 vaccine marketplace -- Vaccinating the Global South -- Not a 'cheap' alternative, but an accessible one -- 'Seizing the opportunity' of the pandemic -- China's key players -- Sinopharm -- Sinovac -- CanSino -- State-corporate cooperation in vaccine development -- Sinopharm: The state takes the lead.
|
505 |
8 |
|
|a Sinovac: Leveraging an eclectic mix of private and public support -- CanSino: Private-military partnership -- The distribution of China's commercial exports of vaccines -- Africa left behind -- Conclusion -- Five Conclusion: Between Politics and Business -- Key arguments and implications -- Looking forward: the future of Chinese vaccines in the Global South -- Challenges -- Opportunities -- A Chinese mRNA vaccine? -- Local manufacturing collaborations -- Closing thoughts -- Notes -- References -- Index -- Back Cover.
|
590 |
|
|
|a JSTOR
|b Books at JSTOR Demand Driven Acquisitions (DDA)
|
590 |
|
|
|a JSTOR
|b Books at JSTOR All Purchased
|
650 |
|
0 |
|a COVID-19 (Disease)
|x Vaccination
|z Developing countries.
|
651 |
|
0 |
|a China
|x Foreign relations
|z Developing countries.
|
651 |
|
0 |
|a Developing countries
|x Foreign relations
|z China.
|
650 |
|
0 |
|a Humanitarian assistance, Chinese
|z Developing countries.
|
650 |
|
0 |
|a Economic assistance, Chinese
|z Developing countries.
|
650 |
|
7 |
|a COVID-19 (Disease)
|x Vaccination
|2 fast
|
650 |
|
7 |
|a Diplomatic relations
|2 fast
|
650 |
|
7 |
|a Economic assistance, Chinese
|2 fast
|
651 |
|
7 |
|a China
|2 fast
|
651 |
|
7 |
|a Developing countries
|2 fast
|
776 |
0 |
8 |
|i Print version:
|z 9781529226324
|
776 |
0 |
8 |
|i Print version:
|z 1529226325
|z 9781529226324
|w (OCoLC)1305913550
|
830 |
|
0 |
|a Bristol shorts research.
|
856 |
4 |
0 |
|u https://jstor.uam.elogim.com/stable/10.2307/j.ctv2z86164
|z Texto completo
|
938 |
|
|
|a Askews and Holts Library Services
|b ASKH
|n AH39619869
|
938 |
|
|
|a YBP Library Services
|b YANK
|n 303177859
|
994 |
|
|
|a 92
|b IZTAP
|